Wk. Williamson et al., PROPHYLACTIC REPAIR OF RENAL-ARTERY STENOSIS IS NOT JUSTIFIED IN PATIENTS WHO REQUIRE INFRARENAL AORTIC RECONSTRUCTION, Journal of vascular surgery, 28(1), 1998, pp. 14-22
Purpose: Simultaneous prophylactic repair of asymptomatic renal artery
stenosis (ARAS) in patients who require infrarenal aortoiliac reconst
ruction is controversial. This study documents the natural history of
ARAS in patients who require aortic reconstruction. Methods: Two hundr
ed patients who required aortic reconstruction from 1985 to 1990 for i
ndications other than hypertension or renal salvage were identified. A
RAS was not repaired. Preoperative angiograms were available for 171 o
f 200 patients and were reviewed for renal artery stenosis. Patients w
ere assessed for atherosclerotic risk factors, survival, preoperative
and follow-up blood pressure, serum creatinine level, antihypertensive
medication usage, and need for dialysis. Results: The mean duration o
f follow-up was 6.3 years. Twenty-four of 171 patients (14%) had preop
erative unilateral 70% to 99% diameter reduction ARAS, and eight (5%)
had bilateral 70% to 99% ARAS. Clinical features associated with great
er than or equal to 70% ARAS included coronary artery disease, increas
ed age, and a diagnosis of hypertension (p < 0.05). Patients with grea
ter than or equal to 70% ARAS did not have a decreased 7-year survival
rate (66% vs 84%; p = 0.10) but had higher systolic blood pressures (
153 +/- 25 vs 138 +/- 30 mm Hg; p < 0.05) as well as increased numbers
of antihypertensive medications at follow-up (1.1 +/- 0.2 vs 0.7 +/-
1; p < 0.05). The mean serum creatinine level (1.1 +/- 0.3 preoperativ
e vs 1.4 +/- 0.8 mg/dl; p = NS) was not increased. One patient (0.58%)
with polycystic kidney disease and minimal renal artery stenosis requ
ired dialysis. Conclusions: High-grade ARAS in patients who are underg
oing infrarenal aortic reconstruction is associated at late follow-up
with increased systolic blood pressure and a need for increased number
s of antihypertensive medications, but not decreased survival rate, di
alysis dependence, or an increase in serum creatinine level. These dat
a do not support renal artery repair in patients with ARAS who undergo
infrarenal aortic reconstruction.